Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ralf Langhoff, MD
Sankt Gertrauden Krankenhaus
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Acibadem City Clinic University Hospital
Sofia, Bulgaria
- University Herzzentrum Bad Krozingen
Bad Krozingen, Germany
- Sankt Gertrauden-Krankenhaus Gmbh
Berlin, Germany
- Cardiovascular Centre Frankfurt
Frankfurt, Germany
- Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer Gmbh
Hamburg, Germany
- Universitätsklinikum Leipzig
Leipzig, Germany
- Elblandklinikum Radebeul
Radebeul, Germany
- Centro Cardiologico Monzino
Milan, Italy
- University Clinic of Cardiology Skopje
Skopje, North Macedonia
- University Medical Center Ljubljana
Ljubljana, Slovenia
- Huntsville Hospital
Huntsville, Alabama, United States
- St. Helena Hospital
St. Helena, California, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Manatee Memorial Hospital
Bradenton, Florida, United States
- Lyerly Baptist Neurosurgery
Jacksonville, Florida, United States
- University of Iowa Hospital and Clinics
Iowa City, Iowa, United States
- University of Lexington
Lexington, Kentucky, United States
- Terrebonne General Medical Center
Houma, Louisiana, United States
- White Oak Medical Center
Silver Spring, Maryland, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- University at Buffalo Neurosurgery
Buffalo, New York, United States
- Mt. Sinai
New York, New York, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- North Carolina Heart and Vascular Research
Raleigh, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- St. Vincent Hospital
Erie, Pennsylvania, United States
- Upmc Hamot
Erie, Pennsylvania, United States
- Pinnacle Health Cardiovascular Institute
Harrisburg, Pennsylvania, United States
- Lankenau Institute
Wynnewood, Pennsylvania, United States
- Miriam Hospital
Providence, Rhode Island, United States
- Prisma Health Midlands
Columbia, South Carolina, United States
- Prisma Health Upstate
Greenville, South Carolina, United States
- Monument Health - Rapid City Regional Hospital
Rapid City, South Dakota, United States
- North Central Heart Institute
Sioux Falls, South Dakota, United States
- Stern Cardiovascular Foundation
Germantown, Tennessee, United States
- Ballad Wellmont Holston Valley Medical Center
Kingsport, Tennessee, United States
- Turkey Creek Medical Center
Knoxville, Tennessee, United States
- Texas Heart Institute
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jun 2020
- Primary completion
- 31 Oct 2023
- Completion
- 31 Dec 2025
- Last update posted
- 6 Jun 2024
- Registered enrollment
- 305
- Registry id
- NCT04201132
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.